New Drug Might Lower Both Bad Cholesterol and Blood Sugar


By: Linda von Wartburg

In two recent studies, WelChol, a drug already approved for lowering LDL (bad) cholesterol was found to lower A1c’s in patients with type 2 diabetes. The first study showed that WelChol, when added to insulin, lowered A1c’s by an average of 0.5% compared to a placebo group.

In the second study, WelChol added to an oral antidiabetic therapy again resulted in mean A1c reductions of 0.5% compared to the placebo group.

As a result of these findings, the manufacturer has applied for approval to market their drug as a one-two punch for both cholesterol and type 2 diabetes. If approved, it will be the first drug to target both conditions.

* * *

Source: WelChol Press Release



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.